Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Government Funding and the Push/Pull Engine

This article was originally published in RPM Report

Executive Summary

The twin concerns of preparing for a breakthrough avian flu virus and for bioterrorism attacks have opened up substantial new funding sources for vaccine development, along with the help of a network of academic centers put together by the National Institutes of Health for expediting clinical trials.The sharp increase in government push money makes the field attractive and one where political skills will play almost as much importance as science.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS080126

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel